With GM Crops, Who Needs Vitamin Pills?

Most soldiers in the biotech revolution think the public will eventually accept genetically modified (GM) foods, thereby ending hostilities. However, science must first offer something of value, such as improved nutrition. Just making life easier for farmers with pest-resistant crops won't outweigh real or imagined risks to people or butterflies. That's the message of a new consumer poll done by Roper Starch Worldwide for the American Farm Bureau Federation.1 Metabolic or nutritional genomics--

Written byBarry Palevitz
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Most soldiers in the biotech revolution think the public will eventually accept genetically modified (GM) foods, thereby ending hostilities. However, science must first offer something of value, such as improved nutrition. Just making life easier for farmers with pest-resistant crops won't outweigh real or imagined risks to people or butterflies. That's the message of a new consumer poll done by Roper Starch Worldwide for the American Farm Bureau Federation.1

Metabolic or nutritional genomics--using genes to improve the nutritional value of plants--excites Dean DellaPenna, professor of biochemistry at the University of Nevada, Reno.2 He's even testified before Congress about it. Says DellaPenna, "I'm enormously hopeful. This has the potential like very few other things to benefit mankind." DellaPenna has reason to be enthusiastic: Recent reports, including one from his own laboratory, point to improved plant output traits in the form of extra vitamins.

Vitamins A and E are linked by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies